Suppr超能文献

印度孟买对药物敏感型肺结核家庭接触者的结核感染检测与治疗方法。

Test and treat approach for tuberculosis infection amongst household contacts of drug-susceptible pulmonary tuberculosis, Mumbai, India.

作者信息

Shah Daksha, Bhide Sampada, Deshmukh Rajesh, Smith Jonathan P, Kaiplyawar Satish, Puri Varsha, Yeldandi Vijay, Date Anand, Nyendak Melissa, Ho Christine S, Moonan Patrick K

机构信息

Brihanmumbai Municipal Corporation, Mumbai, India.

TB Department, Society for Health Allied Research and Education (SHARE) India, Hyderabad, India.

出版信息

Front Tuberc. 2024;2. doi: 10.3389/ftubr.2024.1454277.

Abstract

BACKGROUND

Mumbai is one of the most densely populated areas in the world and is a major contributor to the tuberculosis (TB) epidemic in India. A test and treat approach for TB infection (TBI) amongst household contacts (HHC) is part of the national policy for TB preventive treatment (TPT). However, in practice, the use of interferon-gamma release assay (IGRA) tests for infection are limited, and prevalence of TBI in Mumbai is not known.

METHODS

We conducted a cross-sectional study among HHCs exposed to persons with microbiologically-confirmed, drug-susceptible pulmonary TB that were notified for antituberculosis treatment in Mumbai, India during September-December, 2021. Community-based field workers made home visits and offered IGRA (QuantiFERON-TB Gold In-Tube Plus) tests to HHC aged 5 years and older. After ruling out active TB disease, HHC with IGRA-positive test results were referred for TPT. All HHC were monitored for at least 24 months for progression to active TB disease.

RESULTS

Among 502 HHCs tested, 273 (54%) had IGRA-positive results. A total of 254 (93%) were classified as TBI and were eligible for TPT, of which 215 (85%) initiated TPT, and 194 (90%) completed TPT successfully. There was substantial variation in rates of TBI per household. In 32% of households, all HHC (100%) were IGRA positive and in 64% of households >50% of HHC were infected. In all, 22 HHCs (4%; 22/558) were diagnosed with TB disease; of these, five HHC were diagnosed during follow up, of which three were IGRA positive and had no evidence of disease at initial screening but chose not to initiate TPT.

CONCLUSION

A test and treat strategy for HHC resulted in the detection of a substantial proportion of TBI and secondary TB cases. Home-based IGRA testing led to high participation rates, clinical evaluations, TPT initiation, and early diagnoses of additional secondary cases. A community-focused, test and treat approach was feasible in this population and could be considered for broader implementation.

摘要

背景

孟买是世界上人口最密集的地区之一,也是印度结核病流行的主要促成因素。对家庭接触者(HHC)中的结核感染(TBI)采用检测和治疗方法是国家结核病预防性治疗(TPT)政策的一部分。然而,在实际操作中,用于感染检测的干扰素-γ释放试验(IGRA)检测的使用有限,孟买TBI的患病率尚不清楚。

方法

我们对2021年9月至12月期间在印度孟买因抗结核治疗而被通报的、接触过微生物学确诊的药物敏感型肺结核患者的HHC进行了一项横断面研究。社区现场工作人员进行家访,并为5岁及以上的HHC提供IGRA(管内QuantiFERON-TB Gold Plus)检测。在排除活动性结核病后,IGRA检测结果呈阳性的HHC被转诊接受TPT。对所有HHC进行至少24个月的监测,以观察是否进展为活动性结核病。

结果

在502名接受检测的HHC中,273名(54%)IGRA检测结果呈阳性。共有254名(93%)被归类为TBI,有资格接受TPT,其中215名(85%)开始接受TPT,194名(90%)成功完成TPT。每户家庭的TBI发生率存在很大差异。在32%的家庭中,所有HHC(100%)IGRA检测呈阳性,在64%的家庭中,超过50%的HHC受到感染。共有22名HHC(4%;22/558)被诊断患有结核病;其中,5名HHC在随访期间被诊断出患有结核病,其中3名IGRA检测呈阳性,在初次筛查时没有疾病证据,但选择不开始接受TPT。

结论

针对HHC的检测和治疗策略导致发现了相当比例的TBI和继发性结核病例。基于家庭的IGRA检测导致了高参与率、临床评估、TPT启动以及对其他继发性病例的早期诊断。以社区为重点的检测和治疗方法在该人群中是可行的,可以考虑更广泛地实施。

相似文献

本文引用的文献

9
Prevalence and factors associated with tuberculosis infection in India.印度的结核感染流行情况及相关因素。
J Infect Public Health. 2023 Dec;16(12):2058-2065. doi: 10.1016/j.jiph.2023.10.009. Epub 2023 Oct 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验